AGIOS PHARMACEUTICALS INC. - COMMON STOCK

Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress

15 Jun 2024 08:45:00 By Nasdaq GlobeNewswire

Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET

06 Jun 2024 09:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

05 Jun 2024 09:46:01 By NetDania Notify

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

04 Jun 2024 09:46:58 By NetDania Notify

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

03 Jun 2024 09:51:53 By NetDania Notify

Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia

03 Jun 2024 06:30:00 By Nasdaq GlobeNewswire

Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

30 May 2024 16:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

28 May 2024 09:45:31 By NetDania Notify

Agios Announces $905 Million Purchase Agreement for Vorasidenib Royalty

28 May 2024 07:00:00 By Nasdaq GlobeNewswire

Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress

14 May 2024 10:00:00 By Nasdaq GlobeNewswire

Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024

06 May 2024 07:00:00 By Nasdaq GlobeNewswire

Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024

03 May 2024 07:00:00 By Nasdaq GlobeNewswire

Agios Reports Business Highlights and First Quarter 2024 Financial Results

02 May 2024 07:00:00 By Nasdaq GlobeNewswire

Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024

18 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Agios Publishes 2024 Environmental, Social and Governance (ESG) Report

09 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024

05 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

27 Feb 2024 11:49:59 By NetDania Notify

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

23 Feb 2024 09:46:33 By NetDania Notify

NetDania - New 12 months High: AGIOS PHARMACEUTICALS INC. - COMMON STOCK

22 Feb 2024 12:08:22 By NetDania Notify

Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024

22 Feb 2024 07:00:00 By Nasdaq GlobeNewswire